A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

NCT07086976 ·Status: RECRUITING ·Phase: PHASE3

Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System

NCT06009965 ·Status: UNKNOWN ·Phase: PHASE4

PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy

NCT05676697 ·Status: TERMINATED ·Phase: PHASE1

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

NCT07347990 ·Status: NOT_YET_RECRUITING ·Phase: NA

A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China

NCT06931691 ·Status: RECRUITING

The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia

NCT07287228 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

NCT04820530 ·Status: COMPLETED ·Phase: PHASE3

Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia

NCT05395507 ·Status: RECRUITING ·Phase: PHASE2

The Efficacy and Safety of Alemtuzumab in Auotoimmune Cytopenias

NCT00472433 ·Status: TERMINATED ·Phase: PHASE2

Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders

NCT05086744 ·Status: TERMINATED ·Phase: PHASE2

Avatrombopag Combined With IST as First-line Treatment for SAA

NCT05720234 ·Status: UNKNOWN ·Phase: PHASE2

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

NCT07039422 ·Status: RECRUITING ·Phase: PHASE2

Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia

NCT03825744 ·Status: COMPLETED ·Phase: PHASE3

Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia

NCT01623167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients

NCT04403321 ·Status: COMPLETED ·Phase: PHASE2

A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET

NCT05482971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects

NCT05088642 ·Status: COMPLETED ·Phase: PHASE1

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

NCT02694978 ·Status: COMPLETED ·Phase: PHASE3

Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia

NCT06613880 ·Status: RECRUITING ·Phase: PHASE2

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

NCT03460808 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Efficacy and Safety of Hetrombopag in Non-severe Aplastic Anemia

NCT05018936 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

HID-HSCT Versus IST as First-line Treatment for SAA

NCT07338422 ·Status: NOT_YET_RECRUITING ·Phase: NA

Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults

NCT04518475 ·Status: RECRUITING ·Phase: PHASE4

A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient

NCT03557099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment

NCT01864512 ·Status: WITHDRAWN